Fundraising FoxDeepseq
3 known investors
Find your way into Deepseq
Sign up to see every warm intro you have to Deepseq
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Deepseq team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
DeepSeq designs biologic drugs using AI trained on massive datasets of real protein interactions, predicting properties such as affinity, specificity, immunogenicity, pharmacokinetics, and manufacturability. It aims to accelerate the development of better biologic therapeutics for patients.
Founders & leadership
BS
Bernhard SuterFounderBernhard Suter is a scientist and founder with 15+ years of experience in R&D and technology development in biotech startups and established companies. He spent over 10 years at Next Interactions working on protein sequencing and statistical methods, and currently leads platform and wet lab development at DeepSeq, which uses AI to design biologic drugs.
Investors · 3
Related companies · 3
DeepSeeDeepSee.ai develops technology aimed at supporting knowledge workers and improving business operations. The page provides limited detail beyond a hiring notice.
TempusTempus AI develops artificial intelligence-powered diagnostic tests that integrate genomic, clinical, and imaging data to guide personalized treatment decisions in oncology and other disease areas. The company operates a technology platform that connects healthcare institutions to aggregate and analyze multimodal patient data, serving physicians, pharmaceutical companies, and healthcare systems seeking to optimize therapy selection and drug development.
Deep ChecksDeepchecks offers an enterprise LLM evaluation platform that unifies testing, observability, and monitoring for AI systems in production. It lets AI teams compare prompt/model/agent versions, set up auto-scoring pipelines, create LLM judges and datasets, and integrate LLM app testing into CI/CD.
Companies working in the same space as Deepseq.
Frequently asked questions
- What does Deepseq do?
- DeepSeq designs biologic drugs using AI trained on massive datasets of real protein interactions, predicting properties such as affinity, specificity, immunogenicity, pharmacokinetics, and manufacturability. It aims to accelerate the development of better biologic therapeutics for patients.
- Who founded Deepseq?
- Deepseq was founded by Bernhard Suter.
- Who are Deepseq's investors?
- Deepseq's investors include Illumina Ventures, StartX, ZAKA VC.